Search results for " FIBROSIS"

showing 10 items of 490 documents

Proposed new grading of oral submucous fibrosis based on cheek flexibility.

2013

Objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of oral cavity, pharynx and upper digestive tract, characterized by progressive inability to open the mouth. Based on clinical and/or histopathological features, various classifications and grading systems have been put forth till date. The aim of the present study was to study the variance in cheek flexibility in OSMF patients, the observance of which led to the introduction of a new grading for the condition. Material and Methods: The study included 412 patients with OSMF attending to the Department of Oral Medicine and Radiology during the period from December 2008 to June 2013. A detailed history and examinat…

Pathologymedicine.medical_specialtyOral Medicine and Pathologybusiness.industryResearchPharynxDentistryOdontologíaCheekMalignancymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Upper digestive tractCiencias de la saludstomatognathic diseasesmedicine.anatomical_structureOral submucous fibrosisstomatognathic systemUNESCO::CIENCIAS MÉDICASmedicineEtiologybusinessGeneral DentistryGrading (tumors)Oral medicineJournal of clinical and experimental dentistry
researchProduct

Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis.

2014

<b><i>Objective:</i></b> To compare Masson's trichrome (MT), Sirius red (SR) and orcein staining in acute hepatitis (AH) and to correlate them with<b> </b>transient elastography (TE),<b> </b>a noninvasive method to assess hepatic fibrosis. <b><i>Methods:</i></b> We evaluated liver stiffness by TE in a cohort of 34 consecutive patients and assessed MT-, SR- and orcein-stained biopsies using the METAVIR scoring system and digital image analysis (DIA). <b><i>Results:</i></b> MT and SR both showed severe fibrosis (stage III-IV, DIA = 12.7%). Orcein showed absent or mild fibrosis (stage 0-II, DIA = 4.…

Pathologymedicine.medical_specialtyTransient elastographyContext (language use)Elastic fibrosiSettore MED/08 - Anatomia PatologicaPathology and Forensic Medicinechemistry.chemical_compoundFibrosisTrichromemedicineLiver stiffness measurementStaining methodMolecular BiologyOrceinSirius RedSettore MED/12 - Gastroenterologiabusiness.industryDigital image analysiCell BiologyGeneral Medicinemedicine.diseaseStainingchemistryOrcein stainingTransient elastographyHepatic fibrosisbusinessAcute hepatitiPathobiology : journal of immunopathology, molecular and cellular biology
researchProduct

Role of MUC1 in idiopathic pulmonary fibrosis

2016

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible form of fibrotic intersticial lung disease, characterized by uncontrolled fibroblast proliferative processes and alveolar type II epithelial dysfunction. MUC1 is considered as oncogenic molecule by altering signaling pathways involved in cellular proliferation and cell death. Objective: To analyze the implication of MUC1 in IPF Methods: Lung tissue from 14 healthy and 14 IPF patients was obtained. The expression of MUC1 cytoplasmic tail (CT) and its phosphorylation forms in T-1224 and Y-1229 residues were analyzed by western blot and immunohistochemistry. The effect of MUC1 on TGFβ1-Iinduced epithelia…

Pathologymedicine.medical_specialtybusiness.industry05 social sciencesrespiratory system030204 cardiovascular system & hematologymedicine.diseaserespiratory tract diseases03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicinemedicine.anatomical_structure0502 economics and businessmedicinePhosphorylationImmunohistochemistry050211 marketingEpithelial–mesenchymal transitionSignal transductionFibroblastbusinessMyofibroblastMUC11.5 Diffuse Parenchymal Lung Disease
researchProduct

An interesting approach for the diagnosis of hepatic fibrosis: Wáng et al., “A combined use of intravoxel incoherent motion MRI parameters can differ…

2017

Since its description in 1986 by Le Bihan et al. , intravoxel incoherent motion (IVIM) diffusion MR imaging has made great progresses (1-4). Many studies demonstrated the influence of various pathologies on the diffusion parameters especially in case of cirrhosis and fibrosis. However, few of them are useful at the individual level because of the variability of IVIM values (5). It is indeed very difficult to measure precisely PF and Dfast (6,7). Many published work tried to improve the precision of the measurements, tries to better understand the diffusion patterns, improve the image acquisition sequences or image post-processing. Unfortunately, till today, the reproducibility of the IVIM d…

Pathologymedicine.medical_specialtybusiness.industryCombined useGeneral MedicineIndividual levelMr imagingEditorialMedicineImage acquisitionStage (cooking)businessHepatic fibrosisNuclear medicineIntravoxel incoherent motion
researchProduct

Pancreatitis autoinmune: pseudotumor inflamatorio, afectación multifocal, hipertensión portal y evolución a largo plazo

2008

Autoimmune pancreatitis is a recently characterized disease that still constitutes a diagnostic challenge, especially regarding differential diagnosis from neoplasia. Long-term outcome is poorly known. We herein report a case of a patient with autoimmune pancreatitis and 14 years of follow-up, and show its clinical, biochemical, and morphological characteristics. A 54-year-old female presented with obstructive jaundice and abdominal tenderness, as well as a mass at the pancreatic head on a CT scan, suggestive of pancreatic neoplasia. Surgery showed an increase of the whole pancreas, malignancy was intraoperatively ruled out, and a cholecystectomy and choledochoduodenostomy were carried out.…

Pathologymedicine.medical_specialtybusiness.industryGastroenterologyGeneral MedicineJaundicemedicine.diseaseRetroperitoneal fibrosismedicine.anatomical_structureEsophageal varicesmedicinePortal hypertensionPancreatitismedicine.symptomDifferential diagnosisPancreasbusinessAutoimmune pancreatitisRevista Española de Enfermedades Digestivas
researchProduct

Role of IL-11 in vascular function of pulmonary fibrosis patients

2019

Pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) portends a poor prognosis. Currently, no therapy can improve survival of patients diagnosed with this disease. IL-11 molecular pathway is over-expressed in proliferative disorders, however, its role in PH- associated IPF is unknown. The aim of this study was to evaluated the expression of IL-11 in IPF patients with or without PH. Also we hypothesized that the stimulation of pulmonary artery smooth muscle cells (PASMCs) and human pulmonary artery microvascular endothelial cells (HMVEC-L) with IL-11 induced the transformation into invasive myofibroblast. Human pulmonary artery rings, parenchyma tissue, broncho-alveolar lavage …

Pathologymedicine.medical_specialtybusiness.industryStimulationrespiratory systemmedicine.diseasePulmonary hypertensionrespiratory tract diseases03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicine030228 respiratory systemmedicine.arteryPulmonary arteryParenchymaPulmonary fibrosismedicineDistribution (pharmacology)030212 general & internal medicinebusinessMyofibroblastPulmonary hypertension
researchProduct

Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia.

2003

Bronchopulmonary dysplasia is a chronic lung disease of premature human infancy that shows pathological features comprising varying sized areas of interstitial fibrosis in association with distorted large alveolar spaces. We have previously shown that transfer of active transforming growth factor (TGF)-beta 1 (AdTGF beta 1(223/225)) genes by adenovirus vector to embryonic lungs results in inhibition of branching morphogenesis and primitive peripheral lung development, whereas transfer to adult lungs results in progressive interstitial fibrosis. Herein we show that transfer of TGF-beta1 to newborn rat pups results in patchy areas of interstitial fibrosis developing throughout a period of 28 …

Pathologymedicine.medical_specialtymedicine.medical_treatmentPulmonary FibrosisPathology and Forensic MedicineRats Sprague-DawleyTransforming Growth Factor beta1FibrosisTransforming Growth Factor betaPulmonary fibrosismedicineAnimalsHumansLungBronchopulmonary DysplasiaLungbiologyRespiratory diseaseGene Transfer TechniquesInfant NewbornTransforming growth factor betarespiratory systemmedicine.diseaseRatsDisease Models AnimalCytokinemedicine.anatomical_structureBronchopulmonary dysplasiaAnimals Newbornbiology.proteinAnimal ModelTransforming growth factorThe American journal of pathology
researchProduct

PO-0359 How To Select The Sweat Test Candidate. 10 Years Of Experience In Screening For Cystic Fibrosis In Children

2014

Background Sweat test (ST) remains gold standard in cystic fibrosis (CF) diagnosis. Alarm symptoms are age-related. Aims Retrospective review of cases subjected to ST. Methods Patients were selected by paediatricians, neonatologists, surgeons, based on suggestive symptoms, personal (PH) and familial history (FH). Inclusion criteria: for 0–1 month age group, patients with PH of atelectasis, meconium ileus, intussusception; 1–12 months, recurrent wheezing (RW), failure to thrive (FTT); 1–5 years, previous group symptoms, plus chronic cough/diarrhoea; >5 years, 1–5 years symptoms, plus recurrent pancreatitis/sinusitis. For all age, patients with PH of salty taste of sweat (STS), salt wasting s…

Pediatricsmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryAtelectasismedicine.diseaseCystic fibrosisChronic coughRecurrent pancreatitisPediatrics Perinatology and Child HealthFailure to thrivemedicinePancreatitismedicine.symptombusinessSinusitisSweat testArchives of Disease in Childhood
researchProduct

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

2022

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by an abnormal reepithelialisation, an excessive tissue remodelling and a progressive fibrosis within the alveolar wall that are not due to infection or cancer. Oxidative stress has been proposed as a key molecular process in pulmonary fibrosis development and different components of the redox system are altered in the cellular actors participating in lung fibrosis. To this respect, several activators of the antioxidant machinery and inhibitors of the oxidant species and pathways have been assayed in preclinicalin vitroandin vivomodels and in different clinical trials. This review discusses the role of …

PharmacologyIPF—idiopathic pulmonary fibrosisantioxidant therapyfibrosisoxidative stressPharmacology (medical)Therapeutics. PharmacologyRM1-950Reviewrespiratory systemROS—reactive oxygen speciesrespiratory tract diseasesFrontiers in Pharmacology
researchProduct

Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation.

2022

Stop mutations cause 11% of the genetic diseases, due to the introduction of a premature termination codon (PTC) in the mRNA, followed by the production of a truncated protein. A promising therapeutic approach is the suppression therapy by Translational Readthrough Inducing Drugs (TRIDs), restoring the expression of the protein. Recently, three new TRIDs (NV848, NV914, NV930) have been proposed, and validated by several in vitro assays, for the rescue of the CFTR protein, involved in Cystic Fibrosis disease. In this work, an acute toxicological study for the three TRIDs was conducted in vivo on mice, according to the OECD No.420 guidelines. Animals were divided into groups and treated with …

PharmacologyNonsense mutationCystic Fibrosis Transmembrane Conductance RegulatorGeneral MedicineOxadiazoleMiceDisease Models AnimalPremature termination codon (PTC)Pharmaceutical PreparationsCodon NonsenseProtein BiosynthesisAnimalsToxicity studyTranslational readthrough inducing drugs(TRIDs)Biomedicinepharmacotherapy = Biomedecinepharmacotherapie
researchProduct